Kiyoshi Egawa

Rare Disease / Clinical Research

Hokkaido University Graduate School of Medicine

Japan.

QC-verified· April 2026 1 publication

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Mucopolysaccharidosis type 2

Verify independently

PubMed author search

Other specialists for Mucopolysaccharidosis type 2

Peers ranked by clinical-trial PI role, publications, and verification quality.

Katia Meirelles, MD, M.D
Denali Therapeutics
IL
Markus Ries, MD PhD MHSc FCP
markus.ries@med.uni-heidelberg.de
Makoto Mizushima
Hokkaido University Graduate School of Medicine
Miki Fujimura
Hokkaido University Graduate School of Medicine
Masahito Kawabori
Hokkaido University Graduate School of Medicine
Kazuyoshi Yamazaki
Hokkaido University Graduate School of Medicine
Paul Orchard, MD, MD
University of Minnesota Medical Center
MN
Tippi C MacKenzie, MD
University of California, San Francisco
California

See all specialists for Mucopolysaccharidosis type 2 →

← Back to specialists directory